<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vivian H Chu, MD, MHS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrew Wang, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Catherine M Otto, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 26, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Infective endocarditis (IE) refers to infection of the endocardial surface of the heart; it usually refers to infection of one or more heart valves or infection of an intracardiac device.</p><p>The clinical manifestations and evaluation of adults with suspected left-sided native valve IE will be reviewed here. Issues related to right-sided native valve IE are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2149.html" rel="external">"Right-sided native valve infective endocarditis"</a>.)</p><p>Issues related to risk factors, complications, antimicrobial therapy, surgery, and outcome of native valve IE are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2151.html" rel="external">"Native valve endocarditis: Epidemiology, risk factors, and microbiology"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2142.html" rel="external">"Complications and outcome of infective endocarditis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2148.html" rel="external">"Surgery for left-sided native valve infective endocarditis"</a>.)</p><p></p><p>Issues related to clinical manifestations, diagnosis, and management of prosthetic valve IE and cardiac device infections are also discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2138.html" rel="external">"Prosthetic valve endocarditis: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2146.html" rel="external">"Infections involving cardiac implantable electronic devices: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2141.html" rel="external">"Antimicrobial therapy of prosthetic valve endocarditis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2132.html" rel="external">"Surgery for prosthetic valve endocarditis"</a>.)</p><p></p><p class="headingAnchor" id="H3210980956"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>Risk factors for native valve infective endocarditis (IE) include cardiac factors (history of prior IE or pre-existing valvular or congenital heart disease), underlying conditions (such as intravenous drug use, an indwelling cardiac device or intravenous catheter, or immunosuppression), or a recent dental or surgical procedure. Issues related to risk factors for IE are discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/2151.html" rel="external">"Native valve endocarditis: Epidemiology, risk factors, and microbiology", section on 'Risk factors'</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>The clinical manifestations of infective endocarditis (IE) are variable; IE may present as an acute, rapidly progressive infection or as a subacute or chronic disease with low-grade fever and nonspecific symptoms [<a href="#rid1">1,2</a>]. </p><p class="headingAnchor" id="H557821181"><span class="h2">Symptoms and signs</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Symptoms</strong> – Fever is the most common symptom of IE (up to 90 percent of patients); it is often associated with chills, anorexia, and weight loss. Fever patterns in IE vary widely; their temporal patterns or severity have no diagnostic utility. Patients with IE typically have continuous bacteremia, regardless of whether fever is present. Other common symptoms of IE include malaise, headache, myalgias, arthralgias, night sweats, abdominal pain, and dyspnea [<a href="#rid3">3</a>]. Patients with IE associated with dental infection may report tooth pain or related symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Signs</strong> – A new or changing cardiac murmur is observed in approximately 85 percent of patients. Supportive signs include splenomegaly and cutaneous manifestations such as petechiae or splinter hemorrhages. Petechiae are observed in 20 to 40 percent of patients; they may be present on the skin (usually on the extremities) or on mucous membranes such as the palate or conjunctivae  (<a class="graphic graphic_picture graphicRef57118" href="/z/d/graphic/57118.html" rel="external">picture 1</a>). Splinter hemorrhages consist of nonblanching linear reddish-brown lesions under the nail bed  (<a class="graphic graphic_picture graphicRef72076" href="/z/d/graphic/72076.html" rel="external">picture 2</a>). However, neither their presence nor location are diagnostic of IE, as they are commonly found in otherwise normal patients [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/z/d/html/1078.html" rel="external">"Auscultation of cardiac murmurs in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Relatively uncommon manifestations highly suggestive of IE</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Janeway lesions – Nontender erythematous macules on the palms and soles  (<a class="graphic graphic_picture graphicRef58380" href="/z/d/graphic/58380.html" rel="external">picture 3</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Osler nodes – Tender subcutaneous violaceous nodules mostly on the pads of the fingers and toes, which may also occur on the thenar and hypothenar eminences  (<a class="graphic graphic_picture graphicRef68796" href="/z/d/graphic/68796.html" rel="external">picture 4</a>). Tenderness may be present a few days before appearance of the nodule. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Roth spots – Exudative, edematous hemorrhagic lesions of the retina with pale centers.</p><p></p><p class="bulletIndent1">Janeway lesions are more common in acute than subacute IE; histologically, they reflect microabscesses with neutrophil infiltration of capillaries. Osler nodes and Roth spots occur most frequently in the setting of a protracted time course of endocarditis; they probably represent the sequelae of vascular occlusion by microthrombi leading to localized immune-mediated vasculitis. Roth spots (also described as Litten spots) occur in 2 percent of patients with IE [<a href="#rid5">5</a>]. Osler nodes were commonly observed among patients with IE in the preantibiotic era but are now uncommon since IE is frequently diagnosed and treated before their development.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications as initial presentation</strong> – Clinical manifestations reflecting complications of IE may be present at the time of initial presentation and/or may develop subsequently, as discussed below. When present, such findings warrant independent diagnostic evaluation, concurrent with evaluation for IE. (See <a class="local">'Complications as initial presentation'</a> below.)</p><p></p><p class="headingAnchor" id="H2802726720"><span class="h2">Complications as initial presentation</span><span class="headingEndMark"> — </span>IE is associated with a broad array of systemic complications due to septic embolization, which may be associated with localized thrombosis, bleeding, infection, and/or development of immune reactions. Clinical manifestations reflecting these complications may be present at the time of initial presentation and/or may develop subsequently (see  <a class="medical medical_review" href="/z/d/html/2142.html" rel="external">"Complications and outcome of infective endocarditis"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac complications (up to 50 percent of patients) – Valve regurgitation, heart failure, and conduction abnormalities. In patients with a new diagnosis of valve regurgitation, and in patients with mitral valve prolapse and a new diagnosis of chordal rupture, IE warrants consideration even in the absence of fever. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neurologic complications (up to 40 percent of patients) – Embolic stroke, intracerebral hemorrhage, brain abscess, and others. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Septic emboli (up to 25 percent of patients) – Infarction of kidneys, spleen, and other organs. In patients with concomitant right-sided endocarditis, septic pulmonary emboli may be seen  (<a class="graphic graphic_diagnosticimage graphicRef80439" href="/z/d/graphic/80439.html" rel="external">image 1</a>). (See  <a class="medical medical_review" href="/z/d/html/2149.html" rel="external">"Right-sided native valve infective endocarditis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Metastatic infection (such as vertebral osteomyelitis, septic arthritis, splenic or psoas abscess).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Systemic immune reactions (eg, glomerulonephritis).</p><p></p><p>Detection of the full spectrum of clinical manifestations of IE complications requires a careful, focused initial evaluation as well as serial follow-up examinations. As examples, patients with IE may present with clinical manifestations of congestive heart failure due to valvular regurgitation, focal neurologic complaints due to an embolic stroke, or back pain due to vertebral osteomyelitis. A thorough investigation of extracardiac manifestations is particularly important in the setting of <em>Staphylococcus aureus</em> bacteremia given the virulence of this organism. Issues related to complications of IE are discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/2135.html" rel="external">"Clinical manifestations of Staphylococcus aureus infection in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2142.html" rel="external">"Complications and outcome of infective endocarditis"</a>.)</p><p class="headingAnchor" id="H107317790"><span class="h2">Laboratory and ECG findings</span><span class="headingEndMark"> — </span>Routine laboratory findings in the setting of IE are relatively nonspecific; they may include elevated inflammatory markers (erythrocyte sedimentation rate and/or elevated C-reactive protein), normochromic-normocytic anemia, and positive rheumatoid factor. Hyperglobulinemia, cryoglobulinemia, circulating immune complexes, hypocomplementemia, and false-positive serologic tests for syphilis occur in some patients. Urinalysis may demonstrate microscopic hematuria, proteinuria, and/or pyuria. </p><p>IE-related immune complex-mediated glomerulonephritis (a minor diagnostic criterion for IE) is suggested by acute kidney injury along with hematuria, proteinuria, red blood cell casts, and serologic findings of hypocomplementemia, cryoglobulinemia, and/or presence of circulating immune complexes. (See <a class="local">'Establishing a diagnosis of IE'</a> below.)</p><p>Electrocardiography (ECG) may demonstrate new or evolving conduction disease (first- or second-degree atrioventricular block, bundle branch block, or complete heart block), reflecting paravalvular or myocardial extension of infection [<a href="#rid6">6</a>].</p><p class="headingAnchor" id="H4084836"><span class="h1">EVALUATION</span></p><p class="headingAnchor" id="H2726864653"><span class="h2">When to suspect IE</span><span class="headingEndMark"> — </span>The diagnosis of infective endocarditis (IE) should be suspected in patients with bacteremia due to an organism with known propensity to cause endocarditis; other important clues include fever, relevant cardiac risk factors (prior IE, history of valvular or congenital heart disease), and other predisposing conditions (intravenous drug use, indwelling cardiac device or intravenous catheter, immunosuppression, or a recent dental or surgical procedure).</p><p class="headingAnchor" id="H1380818251"><span class="h2">History and physical examination</span><span class="headingEndMark"> — </span>Clinical history should include assessment of relevant symptoms, including their nature and duration. Physical examination should include cardiac auscultation and evaluation for stigmata of IE. (See <a class="local">'Symptoms and signs'</a> above.)</p><p>Risk factors and comorbid conditions for IE should also be reviewed. (See  <a class="medical medical_review" href="/z/d/html/2151.html" rel="external">"Native valve endocarditis: Epidemiology, risk factors, and microbiology"</a>.). </p><p class="headingAnchor" id="H3936158490"><span class="h2">Blood cultures</span><span class="headingEndMark"> — </span>At least two sets of blood cultures should be obtained from separate venipuncture sites prior to initiation of antibiotic therapy. Three or more blood culture sets are ideal for distinguishing IE from non-IE bloodstream infection in the setting of microbes that are common skin colonizers or are unusual causes of IE. (See  <a class="medical medical_review" href="/z/d/html/2133.html" rel="external">"Detection of bacteremia: Blood cultures and other diagnostic tests"</a>.)</p><p>We obtain follow-up blood cultures 24 to 72 hours after antimicrobial therapy is begun, and repeat every one to three days until clearance of bacteremia is documented [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/2133.html" rel="external">"Detection of bacteremia: Blood cultures and other diagnostic tests"</a> and  <a class="medical medical_review" href="/z/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis", section on 'Empiric therapy'</a>.)</p><p class="headingAnchor" id="H2421826438"><span class="h3">Collection</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Number of blood culture sets</strong> – Blood cultures are the cornerstone of microbiological diagnosis of IE; three blood cultures sets (each set consists of one aerobic bottle and anaerobic bottle) detect 96 to 98 percent of bacteremia [<a href="#rid3">3</a>]. Two blood culture sets are often standard clinical practice; however, in the setting of suspicion for IE, it would be ideal to obtain at least three blood culture sets should be obtained from separate venipuncture sites, prior to initiation of antibiotic therapy [<a href="#rid8">8,9</a>]. </p><p></p><p class="bulletIndent1">In the absence of recent antimicrobial therapy, the diagnostic yield of more than three sets of blood cultures is minimal. In one series including 206 cases of IE, the initial blood culture in patients with streptococcal endocarditis was positive in 96 percent of cases, and one of the first two blood cultures was positive in 98 percent [<a href="#rid10">10</a>]. In patients with IE caused by organisms other than<em> Streptococcus</em>, the first blood culture was positive in 82 percent of cases, and one of the first two cultures was positive in 100 percent of cases [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1">In patients who have received recent antimicrobial therapy, additional blood cultures may be useful (two to three additional sets collected over several days). The utility of repeat blood cultures depends on the underlying clinical circumstances. For example, many patients with<em> S. aureus</em> IE have positive blood cultures for several days after initiation of antimicrobial therapy, whereas patients with IE due to highly susceptible strains of bacteria such as viridans group streptococci may have negative blood cultures after a few doses of antimicrobial therapy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing</strong> – Patients with IE typically have continuous bacteremia; therefore, blood cultures may be collected at any time and need not necessarily be obtained at the time of fever or chills [<a href="#rid11">11</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Volume</strong> – The volume of blood for each blood culture set in adults is 20 mL (10 mL into each bottle). </p><p></p><p>Additional issues related to collecting blood cultures for detection of bacteremia are discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/2133.html" rel="external">"Detection of bacteremia: Blood cultures and other diagnostic tests"</a>.)</p><p class="headingAnchor" id="H1413816360"><span class="h3">Interpretation</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Time to positivity</strong> – Most clinically significant bacteremias are detected within 48 hours; common and fastidious pathogens (such as members of the HACEK group) are usually detected within five days of incubation with modern automated blood culture detection systems. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Typical organisms</strong> – Typical microorganisms consistent with IE include <em>S. aureus,</em> <em>S. lugdunensis,</em> <em>E. faecalis,</em> all streptococcal species (except for <em>S. pneumoniae </em>and <em>S. pyogenes</em>), <em>Granulicatella </em>and <em>Abiotrophia</em> spp., <em>Gemella </em>spp., and HACEK group organisms (<em>Haemophilus </em>spp., <em>Aggregatibacter actinomycetemcomitans</em>, <em>Cardiobacterium hominis</em>, <em>Eikenella corrodens</em>, and <em>Kingella kingae</em>). </p><p></p><p class="bulletIndent1">The likelihood of IE is greater in the setting of bacteremia due to<em> Streptococcus sanguis</em> than<em> Streptococcus milleri </em>[<a href="#rid12">12</a>]. Bacteremia due to group G<em> Streptococcus </em>is more frequently associated with IE than bacteremia due to group A or C streptococci [<a href="#rid13">13</a>]. Bacteremia due to<em> Enterococcus faecalis</em> has been more frequently associated with IE than bacteremia due to other enterococcal species [<a href="#rid14">14</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Organisms in the setting of intracardiac prosthetic material</strong> – Additional microbes should be considered as typical pathogens in the setting of intracardiac prosthetic material: <em>coagulase-negative staphylococci</em>, <em>Corynebacterium striatum </em>and <em>C. jeikeium</em>, <em>Serratia marcescens</em>, <em>Pseudomonas aeruginosa</em>, <em>Cutibacterium acnes</em>, nontuberculous mycobacteria (especially <em>M. chimerae</em>), and <em>Candida spp.</em> The microbiology of IE is discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/2151.html" rel="external">"Native valve endocarditis: Epidemiology, risk factors, and microbiology", section on 'Microbiology'</a> and  <a class="medical medical_review" href="/z/d/html/3178.html" rel="external">"Infections due to the <i>Streptococcus anginosus </i>(<i>Streptococcus milleri</i>) group"</a> and  <a class="medical medical_review" href="/z/d/html/3172.html" rel="external">"Group C and group G streptococcal infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Distinguishing between pathogenicity and contamination</strong> – Organisms for which it can be difficult to distinguish between pathogenicity and contamination include <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>)<em> acnes</em>, <em>Corynebacterium </em>species, <em>Bacillus </em>species, and coagulase-negative staphylococci. In general, the likelihood of pathogenicity is increased if the organism is observed in multiple blood cultures obtained by independent venipunctures. Recovery of these organisms from a single blood culture or a minority of blood culture bottles is more likely to reflect a false-positive result. (See  <a class="medical medical_review" href="/z/d/html/2133.html" rel="external">"Detection of bacteremia: Blood cultures and other diagnostic tests", section on 'Assessing clinical significance'</a>.)</p><p></p><p class="headingAnchor" id="H3576769538"><span class="h2">Cardiac imaging</span></p><p class="headingAnchor" id="H1442032435"><span class="h3">Echocardiography as primary modality</span><span class="headingEndMark"> — </span>Echocardiography should be performed in all patients with suspected IE as soon as possible after the diagnosis of IE is suspected  (<a class="graphic graphic_algorithm graphicRef138355" href="/z/d/graphic/138355.html" rel="external">algorithm 1</a> and <a class="graphic graphic_algorithm graphicRef138356" href="/z/d/graphic/138356.html" rel="external">algorithm 2</a>) [<a href="#rid1">1,15-17</a>]. </p><p>Echocardiography is warranted even for patients with an associated condition that requires a protracted course of antimicrobial therapy (such as vertebral osteomyelitis), since documenting the presence or absence of vegetation is important for determination of subsequent follow-up. (See  <a class="medical medical_review" href="/z/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis", section on 'Follow up'</a>.)</p><p class="headingAnchor" id="H438799105"><span class="h4">Choosing between TTE and TEE</span><span class="headingEndMark"> — </span>In general, transthoracic echocardiography (TTE) is the first diagnostic test for patients with suspected IE. However, transesophageal echocardiography (TEE) has higher sensitivity than TTE and is better for detection of cardiac complications. Data obtained by TTE and TEE are complementary, so both studies are useful in most patients; however, it is reasonable to forgo TTE and proceed to TEE for patients with a prior valvular abnormality (including previous endocarditis) or limited transthoracic windows (eg, due to obesity, chest wall deformity, or mechanical ventilation).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>TTE</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diagnostic scope</strong> – Echocardiography is considered positive for IE in the setting of vegetation or abscess. Other findings, such as intra-cardiac fistula and valve leaflet perforation, also reflect IE but are more challenging to confirm by TTE  (<a class="graphic graphic_movie graphicRef64233" href="/z/d/graphic/64233.html" rel="external">movie 1</a> and <a class="graphic graphic_movie graphicRef52651" href="/z/d/graphic/52651.html" rel="external">movie 2</a> and <a class="graphic graphic_movie graphicRef79209" href="/z/d/graphic/79209.html" rel="external">movie 3</a> and <a class="graphic graphic_movie graphicRef55154" href="/z/d/graphic/55154.html" rel="external">movie 4</a>).</p><p></p><p class="bulletIndent2">Echocardiography is also useful for evaluating valvular dysfunction, assessing hemodynamic severity of the valve lesion, assessing underlying ventricular function, and detecting associated abnormalities such as shunts. In addition, echocardiography is an important tool for follow-up evaluation of patients with persistent or recurrent bacteremia or other clinical deterioration. (See  <a class="medical medical_review" href="/z/d/html/5323.html" rel="external">"Role of echocardiography in infective endocarditis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sensitivity and specificity</strong> – The sensitivity of TTE is modest (up to 75 percent); the specificity approaches 100 percent [<a href="#rid18">18</a>]. False-negative results may be obtained if vegetations are small and/or if vegetations have embolized. Thus, the absence of vegetation on TTE does not preclude the diagnosis of IE, although the presence of normal valve morphology and function on TTE substantially reduces the likelihood of IE [<a href="#rid19">19</a>]. In one study including 134 patients with suspected IE, 96 percent of patients with normal valves and no vegetation on TTE also had a negative TEE [<a href="#rid20">20</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>TEE</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diagnostic scope</strong> – In addition to identification of vegetations, TEE allows evaluation of the severity of valve dysfunction, assessment of left and right ventricular systolic function, and estimation of pulmonary pressures, and it may detect complications of endocarditis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Indications</strong> – TEE is warranted in the following circumstances  (<a class="graphic graphic_algorithm graphicRef138355" href="/z/d/graphic/138355.html" rel="external">algorithm 1</a> and <a class="graphic graphic_algorithm graphicRef138356" href="/z/d/graphic/138356.html" rel="external">algorithm 2</a>) [<a href="#rid1">1,3,21,22</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>TTE without evidence of endocarditis, or TTE technically inadequate, with clinical suspicion for IE (bacteremia due to an organism known to be a common cause of IE, particularly <em>S. aureus</em>, and/or multiple minor criteria for endocarditis) (see <a class="local">'2023 Duke-ISCVID criteria'</a> below)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>TTE with valve vegetation, with concern for presence of intracardiac complications such as paravalvular abscess (risk factors include new conduction delay on ECG, aortic valve endocarditis, and persistent bacteremia or fever despite appropriate antimicrobial therapy)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>TTE with valve vegetation as well as significant valvular regurgitation, to determine need for surgery</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sensitivity and specificity</strong> – TEE has a sensitivity of &gt;90 percent for detection of valvular vegetation and is superior to TTE for detection of cardiac complications such as abscess, leaflet perforation, and aortic pseudoaneurysm or intracardiac fistula. Therefore, TEE is useful in most cases, even if TTE was sufficient to establish the diagnosis of IE [<a href="#rid23">23,24</a>]. Of note, the specificity of TEE is not 100 percent; false-positive findings can occur with cardiac tumors, mural thrombi, or fibrous strands on the aortic valve [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/5323.html" rel="external">"Role of echocardiography in infective endocarditis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Negative echocardiography</strong> <strong>but clinical suspicion for IE persists</strong> – Patients with a negative TEE for whom the clinical suspicion for IE remains high (eg, patients who are at high risk for IE and have persistent bacteremia or fever without another identifiable source, and/or multiple minor criteria for IE) should undergo repeat TEE approximately one week later [<a href="#rid1">1,25</a>]. Repeat TEE is also warranted after an initial positive TEE if clinical features suggest new development of an intracardiac complication [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1">If TTE and TEE are both nondiagnostic, additional imaging tools include cardiac computed tomography (CT) and fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET)/CT. </p><p></p><p class="headingAnchor" id="H4215826638"><span class="h3">Emerging imaging modalities</span><span class="headingEndMark"> — </span>Emerging modalities include cardiac CT and FDG PET/CT: </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiac CT</strong> – Cardiac CT may be helpful for cases in which definitive evidence of IE and its complications cannot be demonstrated with TEE, and/or for planning surgery in patients with extravalvular complications. Cardiac CT has lower sensitivity than echocardiography for vegetations [<a href="#rid26">26</a>] but appears to have higher sensitivity for detection of paravalvular abscess and pseudoaneurysm [<a href="#rid27">27-30</a>]. Cardiac CT may be more informative than TEE when TEE is limited by artifact [<a href="#rid30">30-33</a>].</p><p></p><p class="bulletIndent1">If clinically warranted, CT imaging of the brain and/or torso may be obtained at the same time to evaluate for evidence of systemic embolization [<a href="#rid34">34</a>]. (See <a class="local">'Additional evaluation for IE source or complications'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>FDG PET/CT</strong> – FDG PET/CT can identify infection of native valves and paravalvular areas, as well as extracardiac sites of infection [<a href="#rid35">35,36</a>]. The sensitivity of FDG PET/CT for diagnosis of native valve IE is lower than for prosthetic valve IE; this is likely due to fibrosis in native valve IE, compared with inflammation in prosthetic valve IE [<a href="#rid2">2,37</a>]. </p><p></p><p class="bulletIndent1">Data on use of FDG PET/CT in the setting of suspected native valve IE in include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a meta-analysis including 13 studies and 537 patients who underwent FDG PET/CT, the sensitivity and specificity for diagnosis of endocarditis were 77 and 78 percent, respectively [<a href="#rid38">38</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In one study including 115 patients with suspected native valve IE, when FDG PET/CT evidence of distal septic emboli was used as a minor criterion, 11 out of 26 cases of "possible" were re-classified to "definite" native valve IE [<a href="#rid37">37</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In one study including 70 patients with suspected native valve IE, FDG PET/CT led to a modification in management (mostly antibiotic treatment) in 31 percent of cases [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Extracardiac sites of infection may be detected by FDG PET/CT in 40 to 60 percent of cases of definite IE [<a href="#rid35">35,37,40</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In one study of 140 patients with suspected native and prosthetic valve IE, a previously unsuspected portal of entry was detected in 8 percent of cases [<a href="#rid40">40</a>]. </p><p></p><p class="headingAnchor" id="H2918126971"><span class="h2">Additional evaluation for IE source or complications</span><span class="headingEndMark"> — </span>Additional evaluation for patients with suspected infective endocarditis (IE) includes ECG, chest radiography, other radiographic imaging tailored to clinical manifestations, and dental evaluation.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electrocardiography</strong> – Baseline ECG should be performed as part of the initial evaluation for all patients with suspected IE, with subsequent telemetry monitoring or serial ECGs. The presence of heart block or conduction delay (which may manifest initially as a prolonged PR interval) may provide an important clue to paravalvular extension of infection to the valve annulus and adjacent septum (which should prompt further evaluation with ECG as discussed below). In addition, the presence of findings consistent with ischemia or infarction may suggest the presence of emboli to the coronary circulation. (See  <a class="medical medical_review" href="/z/d/html/2115.html" rel="external">"ECG tutorial: Basic principles of ECG analysis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chest radiography</strong> – Chest radiography is warranted to evaluate for presence of septic pulmonary emboli  (<a class="graphic graphic_diagnosticimage graphicRef80439" href="/z/d/graphic/80439.html" rel="external">image 1</a>), infiltrate (with or without cavitation), congestive heart failure, and potential alternative causes of fever and systemic symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Computed tomography</strong> – CT of the torso (chest, abdomen, and pelvis) is useful to evaluate for sites of metastatic infection (such as splenic infarct, renal infarcts, psoas abscess, or other sites of infection) that may warrant localized drainage [<a href="#rid1">1,41</a>]. However, the decision to pursue this imaging should be guided by a careful history and clinical assessment. In one study including more than 500 patients with possible or definite IE who underwent thoracoabdominal CT, the diagnosis of IE was upgraded from possible to definite in only 0.8 percent of cases; acute kidney injury within five days of imaging was observed in 15 percent of patients [<a href="#rid42">42</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Additional radiographic imaging</strong> – Additional radiographic imaging to evaluate for complications of IE should be tailored to findings on history and physical examination [<a href="#rid1">1</a>]. As examples, patients with back pain should be evaluated for the possibility of vertebral osteomyelitis with imaging studies (see  <a class="medical medical_review" href="/z/d/html/7663.html" rel="external">"Vertebral osteomyelitis and discitis in adults"</a>), and patients with headache, neurologic deficits, or meningeal signs should be evaluated with head magnetic resonance imaging (MRI) for neurologic complications (including intracranial mycotic aneurysm or central nervous system bleeding). (See  <a class="medical medical_review" href="/z/d/html/2129.html" rel="external">"Overview of infected (mycotic) arterial aneurysm"</a>.)</p><p></p><p class="bulletIndent1">Routine brain imaging with CT or MRI is not mandatory in the absence of focal neurologic signs or symptoms. However, since asymptomatic cerebral infarcts are relatively common in patients with IE, their presence can be diagnostically important (as signs of systemic emboli) if they are detected in patients with possible IE based on other findings [<a href="#rid1">1,40,43,44</a>]. As an example, in one study including 53 patients, early use of cerebral MRI led to upgraded classification of IE to definite or possible in one-third of cases [<a href="#rid40">40</a>]. </p><p></p><p class="bulletIndent1">For patients with IE in the absence of neurologic signs or symptoms, brain imaging may be useful if cardiac surgery is being considered or planned. In a systematic review and meta-analysis including 21 studies (mostly retrospective) and more than 2100 patients with suspected or confirmed IE who underwent brain MRI, acute ischemic lesions or microbleeds were observed in more than half of cases; hemorrhagic lesions, abscess, meningitis, and intracranial mycotic aneurysms were observed less commonly [<a href="#rid45">45</a>]. Similarly, in a retrospective study including 155 patients with IE in the absence of neurologic signs or symptoms, cerebral imaging demonstrated a new surgical indication (defined as a cerebral embolic event in the presence of a left-sided vegetation &gt;10mm) in 19 percent of cases [<a href="#rid46">46</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dental evaluation</strong> – Patients with IE should undergo a thorough dental evaluation; the examination should focus on periodontal inflammation, pocketing around teeth, and caries that may result in pulpal infection and subsequent abscess [<a href="#rid1">1</a>]. All active sources of oral infection should be eradicated, and patients should be counseled regarding the importance of daily dental hygiene with serial dental evaluation. (See  <a class="medical medical_review" href="/z/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis", section on 'Follow up'</a>.)</p><p></p><p class="headingAnchor" id="H509646296"><span class="h2">Evaluation of resected valve</span><span class="headingEndMark"> — </span>The clinical diagnosis of IE may be established via pathologic criteria, which include presence of microorganisms or histopathologic findings of active endocarditis. Culture, staining, immunologic techniques, polymerase chain reaction (PCR), or other nucleic acid-based tests of resected heart valves may be useful for cases in which blood cultures are negative. However, routine use of these tools is not warranted in the absence of clinical suspicion for IE because they may be associated with false-positive results. In one study including 1030 valves removed at surgery, cultures were positive in 39 percent of patients that met Duke criteria for IE and in 28 percent of patients without other criteria for IE [<a href="#rid47">47</a>].</p><p class="headingAnchor" id="H4166950965"><span class="h1">ESTABLISHING A DIAGNOSIS OF IE</span><span class="headingEndMark"> — </span>The diagnosis of infective endocarditis (IE) is established based on clinical manifestations, blood cultures (or other microbiologic data), and cardiac imaging [<a href="#rid3">3</a>]. The diagnosis of IE requires (1) identification of the infecting pathogen by culture, serologic testing, or molecular testing and (2) cardiac imaging to identify a valvular vegetation, paravalvular abscess, or other structural complication of infection. The accepted criteria for diagnosis of IE are the 2023 Duke-International Society for Cardiovascular Infectious Disease (ISCVID) criteria [<a href="#rid48">48,49</a>], which were updated from the 2000 modified Duke criteria [<a href="#rid49">49</a>]. These criteria are summarized below.</p><p class="headingAnchor" id="H1380899019"><span class="h2">2023 Duke-ISCVID criteria</span><span class="headingEndMark"> — </span>The 2023 Duke-International Society for Cardiovascular Infectious Disease (ISCVID) criteria for IE [<a href="#rid48">48</a>] were updated from the 2000 modified Duke criteria [<a href="#rid49">49,50</a>]. The 2023 European Society for Cardiology (ESC) Guidelines for the Management of Endocarditis has an updated schema for the diagnosis of IE [<a href="#rid2">2</a>], which is similar to that of the Duke-ISCVID criteria. </p><p>The criteria should be used as a diagnostic guide together with clinical judgment and must be interpreted in the context of the pretest probability for IE. </p><p class="headingAnchor" id="H1497918164"><span class="h3">IE definitions</span></p><p class="headingAnchor" id="H2847579242"><span class="h4">Definite IE</span><span class="headingEndMark"> — </span>Definite IE is established if pathologic criteria (either microbiologic or histopathologic criteria)<strong> </strong>or clinical criteria outlined below are met. Most patients with suspected IE do not meet pathologic criteria and the diagnosis often relies on clinical features.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathologic criteria</strong> (either microbiologic or histopathologic criteria):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Microbiologic criteria </strong>– Microorganisms identified in the context of clinical signs of active endocarditis:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>In a vegetation</p><p class="bulletIndent3"><span class="glyph">-</span>From cardiac tissue</p><p class="bulletIndent3"><span class="glyph">-</span>From an explanted prosthetic valve or sewing ring</p><p class="bulletIndent3"><span class="glyph">-</span>From an ascending aortic graft (with concomitant evidence of valve involvement)</p><p class="bulletIndent3"><span class="glyph">-</span>From an endovascular cardiac implantable electronic device (CIED)</p><p class="bulletIndent3"><span class="glyph">-</span>From an embolus</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Histopathologic criteria</strong> – Histopathologic findings of active endocarditis identified (may be acute or subacute/chronic):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>In or on a vegetation</p><p class="bulletIndent3"><span class="glyph">-</span>From cardiac tissue </p><p class="bulletIndent3"><span class="glyph">-</span>From an explanted prosthetic valve or sewing ring</p><p class="bulletIndent3"><span class="glyph">-</span>From an ascending aortic graft (with concomitant evidence of valve involvement)</p><p class="bulletIndent3"><span class="glyph">-</span>From a CIED</p><p class="bulletIndent3"><span class="glyph">-</span>From an embolus</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical criteria</strong> (see <a class="local">'Clinical criteria'</a> below)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Two major clinical criteria</p><p class="bulletIndent2"><span class="glyph">•</span>One major and three minor clinical criteria</p><p class="bulletIndent2"><span class="glyph">•</span>Five minor clinical criteria</p><p></p><p class="headingAnchor" id="H359632900"><span class="h4">Possible IE</span><span class="headingEndMark"> — </span>Possible IE is defined as either of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>One major and one minor clinical criteria</p><p class="bulletIndent1"><span class="glyph">●</span>Three minor clinical criteria</p><p></p><p class="headingAnchor" id="H2962909636"><span class="h4">Rejected IE</span><span class="headingEndMark"> — </span>The diagnosis of IE may be rejected if any of the following is present:</p><p class="bulletIndent1"><span class="glyph">●</span>A firm alternate diagnosis explaining signs and symptoms is made</p><p class="bulletIndent1"><span class="glyph">●</span>Lack of recurrence despite antibiotic therapy for &lt;4 days</p><p class="bulletIndent1"><span class="glyph">●</span>No pathologic evidence of infective endocarditis is found at surgery or autopsy after antibiotic therapy for four days or less</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical criteria for possible or definite infective endocarditis are not met</p><p></p><p class="headingAnchor" id="H3106603840"><span class="h3">Clinical criteria</span><span class="headingEndMark"> — </span>Many patients with suspected IE do not meet sufficient criteria for definite IE. In the absence of pathologic criteria, clinical criteria (major and minor) for the diagnosis of IE are summarized below.</p><p class="headingAnchor" id="H1076471313"><span class="h4">Major criteria</span><span class="headingEndMark"> — </span>Major clinical criteria include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiologic criteria</strong> (either positive blood cultures or positive laboratory test)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Positive blood cultures</strong> (one of the following):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Microorganisms that commonly cause IE,<sup> </sup>isolated from two or more separate blood culture sets</p><p class="bulletIndent3"><span class="glyph">-</span>Microorganisms that occasionally or rarely cause IE, isolated from three or more separate blood culture sets</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Positive laboratory test</strong> (one of the following):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Positive PCR or other nucleic acid-based technique<sup> </sup>from blood for <em>Coxiella burnetii</em>, <em>Bartonella</em> spp., or <em>Tropheryma whipplei</em> </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><em>Coxiella burnetii</em> antiphase I immunoglobulin G (IgG) antibody titer &gt;1:800 or <em>Coxiella burnetii</em> isolated from a single blood culture</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Indirect immunofluorescence assays for detection of IgM and IgG antibodies to<em> Bartonella henselae</em> or<em> Bartonella quintana</em>, with IgG titer ≥1:800</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging criteria</strong> (either of the following):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Echocardiography and/or cardiac computed tomography (CT) imaging </strong>(any of the following):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Echocardiography<strong> </strong>and/or cardiac CT demonstrating vegetation, valvular/leaflet perforation, valvular/leaflet aneurysm, abscess, pseudoaneurysm, or intracardiac fistula</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Significant new valvular regurgitation on echocardiography, compared with previous imaging; worsening or changing of pre-existing regurgitation is not sufficient</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>New partial dehiscence of prosthetic valve (compared with previous imaging)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>[</strong><strong><sup>18</sup></strong><strong>F]-FDG PET/CT imaging</strong> </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Abnormal metabolic activity involving a native or prosthetic valve (at least three months after implantation), ascending aortic graft (with concomitant evidence of valve involvement), intracardiac device leads, or other prosthetic material</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgical major criterion </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evidence of IE observed by direct inspection during cardiac surgery, in the absence of major microbiologic or imaging criteria, and in the absence of pathologic (microbiologic or histologic) criteria</p><p></p><p class="headingAnchor" id="H3581700733"><span class="h4">Minor criteria</span><span class="headingEndMark"> — </span>Minor clinical criteria include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Predisposition </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Previous history of IE </p><p class="bulletIndent2"><span class="glyph">•</span>Prosthetic valve</p><p class="bulletIndent2"><span class="glyph">•</span>Previous valve repair</p><p class="bulletIndent2"><span class="glyph">•</span>Congenital heart disease</p><p class="bulletIndent2"><span class="glyph">•</span>More than mild regurgitation or stenosis (of any etiology)  </p><p class="bulletIndent2"><span class="glyph">•</span>Endovascular CIED </p><p class="bulletIndent2"><span class="glyph">•</span>Hypertrophic obstructive cardiomyopathy </p><p class="bulletIndent2"><span class="glyph">•</span>Injection drug use</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fever </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Temperature ≥38.0°C (100.4°F)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vascular phenomena </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Clinical or radiographic evidence of arterial emboli, septic pulmonary infarcts, cerebral or splenic abscess, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages, Janeway lesions, purulent purpura</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunologic phenomena </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Positive rheumatoid factor, Osler nodes, Roth spots, or immune complex-mediated glomerulonephritis</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiologic evidence</strong> (not meeting major criteria)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Positive blood cultures for a microorganism consistent with IE but not meeting requirements for major criteria</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Positive culture, PCR, or other nucleic acid-based test (amplicon or shotgun sequencing, in situ hybridization) for an organism consistent with IE from a sterile body site other than cardiac tissue, cardiac prosthesis, or embolus; or a single finding of a skin bacterium by PCR on a valve or wire without additional clinical or microbiologic supporting evidence</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Abnormal metabolic activity detected by [<sup>18</sup>F]-FDG PET/CT<strong> within</strong> three months of implantation of prosthetic valve, ascending aortic graft (with concomitant evidence of valve involvement), intracardiac device leads or other prosthetic material</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical examination </strong>(if echocardiography is not available)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>New valvular regurgitation identified on auscultation (based on expert opinion); worsening or changing of pre-existing murmur not sufficient </p><p></p><p class="headingAnchor" id="H2867404527"><span class="h2">Basis for Duke criteria revision</span><span class="headingEndMark"> — </span>The 2023 Duke-ISCVID criteria [<a href="#rid48">48</a>] were updated from the 2000 modified Duke criteria [<a href="#rid49">49</a>]; they were developed to reflect in the epidemiology of IE along with the emergence of newer imaging and microbiologic diagnostic tools. Examples of changes in epidemiology and diagnostics which inform the 2023 Duke-ISCVID criteria, particularly with respect to native valve IE include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Changes in our understanding of the epidemiology of IE </strong>– </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong><em>E. faecalis</em></strong> – In the 2023 Duke-ISCVID criteria, <em>E. faecalis </em>is classified as a typical cause of IE regardless of acquisition (community- or healthcare-associated) and regardless of whether there is a primary extracardiac focus of infection. In the 2000 modified Duke criteria, <em>E. faecalis </em>was included as a major criterion only if community-acquired and in the absence of a primary focus. </p><p></p><p class="bulletIndent2">This change is supported by a prospective study including more than 340 patients with <em>E. faecalis </em>bacteremia evaluated with echocardiography; consideration of <em>E. faecalis </em>as a "typical" endocarditis pathogen (regardless of the place of acquisition or the portal of entry) improved the sensitivity for identification of definite endocarditis from 70 to 96 percent [<a href="#rid51">51</a>]. These findings suggest in patients with <em>E. faecalis </em>bacteremia, the potential for IE is significant (even in the setting of healthcare acquisition or extracardiac focus).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other organisms</strong> – Additional organisms considered typical causes of IE added as major microbiologic criteria include <em>S. lugdunensis</em>, all streptococci except <em>S. pneumoniae</em> and <em>S. pyogenes</em>, <em>Granulicatella</em> spp, <em>Abiotrophia</em> spp, and <em>Gemella</em> spp.</p><p></p><p class="bulletIndent2">For intracardiac prosthetic material, organisms added as major microbiological criteria include coagulase-negative staphylococci, <em>Corynebacterium striatum</em>, <em>Corynebacterium jeikeium</em>, <em>Serratia marcescens</em>, <em>Pseudomonas aeruginosa</em>, <em>Cutibacterium acnes</em>, nontuberculous mycobacteria, and <em>Candida</em> spp. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Advances in microbiologic diagnostic testing</strong> – Advances in microbiologic diagnostic testing include PCR of tissue or other sterile body site (such as amplicon or metagenomic sequencing and in situ hybridization), in addition to blood culture and serology.</p><p></p><p class="bulletIndent1">New major microbiologic criteria include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Blood PCR or amplicon/metagenomic sequencing identifying <em>Coxiella burnetii</em>, <em>Bartonella</em> spp, or <em>Tropheryma whipplei</em> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>IFA for detection of antibodies to <em>B. henselae</em> or <em>B. quintana</em>, with IgG titer &gt;1:800 </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Advances in imaging </strong>–<strong> </strong>Advances in imaging include improved understanding of the diagnostic utility of cardiac CT and FDG PET/CT for detection of IE, which were added as major imaging criteria. (See <a class="local">'Emerging imaging modalities'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Value of operative findings</strong> – It has been recognized that intraoperative inspection of cardiac pathology is valuable, particularly for situations in which supportive histopathologic, microbiologic, or imaging data are not available.</p><p></p><p class="headingAnchor" id="H2006242341"><span class="h2">Validation of Duke criteria</span><span class="headingEndMark"> — </span>The 2023 Duke-ISCVID criteria have undergone validation studies using an adjudication panel of experts to determine the diagnosis of IE as the reference standard:</p><p class="bulletIndent1"><span class="glyph">●</span>In a study including 595 patients with suspected IE in Amsterdam, the 2023 Duke-ISCVID Criteria had higher sensitivity for the diagnosis of IE than the modified Duke criteria (2000) or the ESC 2015 criteria (84, 75, and 80 percent, respectively); the specificity was similar among all three criteria (94 percent) [<a href="#rid52">52</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a study including 1194 patients in France, the sensitivity of the 2023 Duke-ISCVID criteria was higher than the modified Duke criteria (2000) and the ESC 2015 criteria (98, 93, and 95 percent, respectively) [<a href="#rid53">53</a>]. However, in this study the specificities were low for all of the criteria (46, 61, and 61 percent); this is due in part to the addition of positive culture or PCR from a percutaneously extracted CIED, findings which were often not accepted as major criteria for definite IE by the reference adjudicators. </p><p></p><p class="headingAnchor" id="H2561123772"><span class="h2">Culture-negative endocarditis</span><span class="headingEndMark"> — </span>Culture-negative IE is defined as endocarditis with no definitive microbiologic etiology following inoculation of at least three independently obtained blood samples in a standard blood-culture system, with negative cultures after five days of incubation and subculturing.</p><p>There are three main categories of culture-negative IE: IE due to bacterial pathogens whose growth in culture is prevented by antecedent antimicrobial therapy; IE due to microorganisms with fastidious growth characteristics in vitro (such as <em>Gemella</em>, <em>Granulicatella</em>, and <em>Abiotrophia</em> species); and IE due to intracellular bacteria that cannot be cultured from blood using standard microbiologic testing methods [<a href="#rid54">54</a>].</p><p>Culture-negative IE should be suspected in patients with negative blood cultures and persistent fever with one or more clinical findings consistent with IE (eg, stroke or other manifestations of emboli). Culture-negative IE should also be suspected in patients with vegetation on echocardiogram and no clear microbiologic diagnosis. Some causes of culture-negative IE may be identified via serology or PCR; these include <em>Coxiella burnetii</em>, <em>Bartonella</em> spp., <em>Chlamydia</em> spp., <em>Tropheryma whipplei</em>, <em>Legionella</em> spp., <em>Mycoplasma</em>, and <em>Brucella</em> [<a href="#rid48">48</a>].</p><p class="headingAnchor" id="H4086925"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis for endocarditis is broad and should be considered based on two clinical categories: presence of bacteremia in the absence of valvular vegetation and presence of valvular vegetation(s) in the absence of bacteremia.</p><p>Patients with bacteremia in the absence of evidence for valvular vegetation should be evaluated for alternative causes of bacteremia (which may coexist with IE), including:</p><p class="bulletIndent1"><span class="glyph">●</span>Intravascular catheter infection – Catheter-related infection should be suspected when bacteremia occurs in the setting of a central venous catheter with no other apparent source. The diagnosis is established based on evaluation of samples drawn from the catheter and a peripheral vein. (See  <a class="medical medical_review" href="/z/d/html/3813.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Clinical manifestations and diagnosis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac device infection – Cardiac device infection should be suspected in the setting of an implanted device with overlying inflammation. Echocardiography is warranted to evaluate for device-related endocarditis. (See  <a class="medical medical_review" href="/z/d/html/2146.html" rel="external">"Infections involving cardiac implantable electronic devices: Epidemiology, microbiology, clinical manifestations, and diagnosis", section on 'Forms of infection'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prosthetic joint infection – Prosthetic joint infection should be suspected in the setting of a prosthetic joint with local erythema or tenderness. Evaluation of joint fluid or tissue is required to establish the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/7664.html" rel="external">"Prosthetic joint infection: Epidemiology, microbiology, clinical manifestations, and diagnosis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hematogenous osteomyelitis – Hematogenous osteomyelitis should be suspected in the setting of focal pain at an involved site. Evaluation with radiographic imaging is warranted; the involved pathogen may be established by bone biopsy. (See  <a class="medical medical_review" href="/z/d/html/7668.html" rel="external">"Nonvertebral osteomyelitis in adults: Clinical manifestations and diagnosis", section on 'Hematogenous osteomyelitis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Septic thrombophlebitis – Septic thrombophlebitis should be suspected in the setting of persistent bacteremia in the presence of an intravascular catheter or prior intravascular catheter. Patients may present with erythema, edema, palpable cord, or drainage from the site of the involved vessel. (See  <a class="medical medical_review" href="/z/d/html/2131.html" rel="external">"Catheter-related septic thrombophlebitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infected arterial aneurysm – An infected arterial aneurysm should be suspected in patients with a risk factor for arterial injury (such as recent vascular procedure, history of endocarditis), pre-existing aneurysm, or presence of a vascular graft. (See  <a class="medical medical_review" href="/z/d/html/2129.html" rel="external">"Overview of infected (mycotic) arterial aneurysm"</a>.)</p><p></p><p>Patients with valvular vegetation(s) or arterial emboli in the absence of bacteremia may have culture-negative endocarditis or sterile vegetation(s) (marantic endocarditis or Libman-Sachs endocarditis) due to a noninfectious etiology or antiphospholipid syndrome. (See  <a class="medical medical_review" href="/z/d/html/4678.html" rel="external">"Diagnosis of antiphospholipid syndrome"</a>.)</p><p class="headingAnchor" id="H4244121352"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/112042.html" rel="external">"Society guideline links: Treatment and prevention of infective endocarditis"</a>.)</p><p class="headingAnchor" id="H348974587"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/17037.html" rel="external">"Patient education: Endocarditis (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H25"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition and risk factors</strong> − Native valve infective endocarditis (IE) refers to infection of the endocardial surface of the heart; it usually refers to infection of one or more heart valves. Risk factors for IE include cardiac factors (history of prior IE or history of valvular or congenital heart disease) and noncardiac factors (intravenous drug use, indwelling intravenous catheter, immunosuppression, or a recent dental or surgical procedure). (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations </strong>– The clinical manifestations of IE are highly variable; IE may present as an acute, rapidly progressive infection or as a subacute or chronic disease with low-grade fever and nonspecific symptoms. Fever is the most common symptom of IE (up to 90 percent of cases); it is often associated with chills, anorexia, and weight loss. Other symptoms of IE include malaise, headache, myalgias, arthralgias, night sweats, abdominal pain, dyspnea, cough, and pleuritic pain. Cardiac murmurs are observed in approximately 85 percent of patients. Supportive signs include cutaneous manifestations such as petechiae  (<a class="graphic graphic_picture graphicRef57118" href="/z/d/graphic/57118.html" rel="external">picture 1</a>), splinter hemorrhages  (<a class="graphic graphic_picture graphicRef72076" href="/z/d/graphic/72076.html" rel="external">picture 2</a>), Janeway lesions, or Osler nodes. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications </strong>– IE is associated with a broad array of systemic complications; these include cardiac and neurologic complications, septic emboli, metastatic infection, and systemic immune reactions. Clinical manifestations reflecting these complications may be present at the time of initial presentation and/or may develop subsequently. Clinical manifestations of a complication of IE warrant independent diagnostic evaluation, concurrent with evaluation for IE. (See <a class="local">'Complications as initial presentation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic approach</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical suspicion</strong> – The diagnosis of IE should be suspected in patients with bacteremia due to an organism with known propensity to cause endocarditis; other important clues include fever, relevant cardiac risk factors (prior IE, history of valvular, or congenital heart disease), and other predisposing conditions (intravenous drug use, indwelling intravenous lines, immunosuppression, or a recent dental or surgical procedure). (See <a class="local">'When to suspect IE'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Establishing a diagnosis </strong>– The diagnosis of IE is established based on clinical manifestations, blood cultures (or other microbiologic data), and echocardiography (additional imaging such as cardiac CT or FDG PET/CT may be useful if the transesophageal echocardiography [TEE] is nondiagnostic and clinical suspicion persists). The accepted criteria for diagnosis of IE are the 2023 Duke-International Society for Cardiovascular Infectious Disease (ISCVID) criteria, which are summarized above. (See <a class="local">'Establishing a diagnosis of IE'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood cultures: Collection and interpretation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Obtaining blood cultures and empiric treatment </strong>– At least two sets of blood cultures should be obtained from separate venipuncture sites prior to initiation of antibiotic therapy. (See <a class="local">'Blood cultures'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Typical microorganisms</strong> (see <a class="local">'Interpretation'</a> above)<strong> </strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Typical microorganisms consistent with IE include <em>S. aureus</em>, <em>S. lugdunensis</em>, <em>E. faecalis</em>, all streptococcal species (except for <em>S. pneumoniae</em> and <em>S. pyogenes</em>), <em>Granulicatella</em> and <em>Abiotrophia </em>spp., <em>Gemella </em>spp., and HACEK group organisms (<em>Haemophilus</em> spp., <em>Aggregatibacter actinomycetemcomitans</em>, <em>Cardiobacterium hominis</em>, <em>Eikenella corrodens</em>, and <em>Kingella kingae</em>).</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>In the setting of intracardiac prosthetic material, additional microbes should be considered as typical pathogens:<em> coagulase-negative staphylococci</em>,<em> Corynebacterium striatum </em>and<em> C. jeikeium</em>, <em>Serratia marcescens</em>, <em>Pseudomonas aeruginosa</em>, <em>Cutibacterium acnes</em>, nontuberculous mycobacteria (especially <em>M. chimerae</em>), a<em>nd Candida </em>spp. The microbiology of IE is discussed further separately. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Culture-negative IE </strong>– Culture-negative IE should be suspected in patients with negative blood cultures and persistent fever with one or more clinical findings consistent with infective endocarditis (eg, stroke or other manifestations of emboli). Culture-negative IE should also be suspected in patients with vegetation on echocardiogram and no clear microbiologic diagnosis. Serologies and polymerase chain reaction (PCR) of excised valves can be used to investigate for infectious causes of culture-negative IE. (See <a class="local">'Culture-negative endocarditis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiac imaging</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Echocardiography should be performed in patients with suspected IE  (<a class="graphic graphic_algorithm graphicRef138355" href="/z/d/graphic/138355.html" rel="external">algorithm 1</a> and <a class="graphic graphic_algorithm graphicRef138356" href="/z/d/graphic/138356.html" rel="external">algorithm 2</a>). In general, transthoracic echocardiography (TTE) is the first diagnostic test for patients with suspected IE. TEE has higher sensitivity than TTE and is better for detection of cardiac complications such as abscess, leaflet perforation, and pseudoaneurysm. In some circumstances, it is reasonable to forgo TTE and proceed to TEE. (See <a class="local">'Echocardiography as primary modality'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In the setting of nondiagnostic TEE and persistent suspicion for IE, additional imaging tools include cardiac CT and FDG PET/CT. (See <a class="local">'Emerging imaging modalities'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Additional evaluation </strong>– Additional evaluation for patients with suspected IE includes ECG, chest radiography, other radiographic imaging tailored to clinical manifestations and dental evaluation. (See <a class="local">'Additional evaluation for IE source or complications'</a> above.)</p><p></p><p class="headingAnchor" id="H1701819671"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Vance G Fowler, Jr, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Baddour LM, Wilson WR, Bayer AS, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2015; 132:1435.</a></li><li><a class="nounderline abstract_t">Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 2023; 44:3948.</a></li><li><a class="nounderline abstract_t">Cahill TJ, Prendergast BD. Infective endocarditis. Lancet 2016; 387:882.</a></li><li><a class="nounderline abstract_t">GROSS NJ, TALL R. CLINICAL SIGNIFICANCE OF SPLINTER HAEMORRHAGES. Br Med J 1963; 2:1496.</a></li><li><a class="nounderline abstract_t">Loughrey PB, Armstrong D, Lockhart CJ. Classical eye signs in bacterial endocarditis. QJM 2015; 108:909.</a></li><li><a class="nounderline abstract_t">Meine TJ, Nettles RE, Anderson DJ, et al. Cardiac conduction abnormalities in endocarditis defined by the Duke criteria. Am Heart J 2001; 142:280.</a></li><li><a class="nounderline abstract_t">Fowler VG Jr, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998; 27:478.</a></li><li><a class="nounderline abstract_t">Lee A, Mirrett S, Reller LB, Weinstein MP. Detection of bloodstream infections in adults: how many blood cultures are needed? J Clin Microbiol 2007; 45:3546.</a></li><li><a class="nounderline abstract_t">Cockerill FR 3rd, Wilson JW, Vetter EA, et al. Optimal testing parameters for blood cultures. Clin Infect Dis 2004; 38:1724.</a></li><li><a class="nounderline abstract_t">Werner AS, Cobbs CG, Kaye D, Hook EW. Studies on the bacteremia of bacterial endocarditis. JAMA 1967; 202:199.</a></li><li><a class="nounderline abstract_t">Beeson PB, Brannon ES, Warren JV. OBSERVATIONS ON THE SITES OF REMOVAL OF BACTERIA FROM THE BLOOD IN PATIENTS WITH BACTERIAL ENDOCARDITIS. J Exp Med 1945; 81:9.</a></li><li><a class="nounderline abstract_t">Woo PC, Tse H, Chan KM, et al. "Streptococcus milleri" endocarditis caused by Streptococcus anginosus. Diagn Microbiol Infect Dis 2004; 48:81.</a></li><li><a class="nounderline abstract_t">Parker MT, Ball LC. Streptococci and aerococci associated with systemic infection in man. J Med Microbiol 1976; 9:275.</a></li><li><a class="nounderline abstract_t">Anderson DJ, Murdoch DR, Sexton DJ, et al. Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study. Infection 2004; 32:72.</a></li><li><a class="nounderline abstract_t">Lindner JR, Case RA, Dent JM, et al. Diagnostic value of echocardiography in suspected endocarditis. An evaluation based on the pretest probability of disease. Circulation 1996; 93:730.</a></li><li><a class="nounderline abstract_t">Gould FK, Denning DW, Elliott TS, et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2012; 67:269.</a></li><li><a class="nounderline abstract_t">Writing Committee Members, Otto CM, Nishimura RA, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021; 77:e25.</a></li><li><a class="nounderline abstract_t">Habib G, Badano L, Tribouilloy C, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr 2010; 11:202.</a></li><li><a class="nounderline abstract_t">Bai AD, Steinberg M, Showler A, et al. Diagnostic Accuracy of Transthoracic Echocardiography for Infective Endocarditis Findings Using Transesophageal Echocardiography as the Reference Standard: A Meta-Analysis. J Am Soc Echocardiogr 2017; 30:639.</a></li><li><a class="nounderline abstract_t">Irani WN, Grayburn PA, Afridi I. A negative transthoracic echocardiogram obviates the need for transesophageal echocardiography in patients with suspected native valve active infective endocarditis. Am J Cardiol 1996; 78:101.</a></li><li><a class="nounderline abstract_t">Rasmussen RV, Høst U, Arpi M, et al. Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography. Eur J Echocardiogr 2011; 12:414.</a></li><li><a class="nounderline abstract_t">Incani A, Hair C, Purnell P, et al. Staphylococcus aureus bacteraemia: evaluation of the role of transoesophageal echocardiography in identifying clinically unsuspected endocarditis. Eur J Clin Microbiol Infect Dis 2013; 32:1003.</a></li><li><a class="nounderline abstract_t">De Castro S, Cartoni D, d'Amati G, et al. Diagnostic accuracy of transthoracic and multiplane transesophageal echocardiography for valvular perforation in acute infective endocarditis: correlation with anatomic findings. Clin Infect Dis 2000; 30:825.</a></li><li><a class="nounderline abstract_t">Daniel WG, Mügge A, Martin RP, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 1991; 324:795.</a></li><li><a class="nounderline abstract_t">Vieira ML, Grinberg M, Pomerantzeff PM, et al. Repeated echocardiographic examinations of patients with suspected infective endocarditis. Heart 2004; 90:1020.</a></li><li><a class="nounderline abstract_t">Kim IC, Chang S, Hong GR, et al. Comparison of Cardiac Computed Tomography With Transesophageal Echocardiography for Identifying Vegetation and Intracardiac Complications in Patients With Infective Endocarditis in the Era of 3-Dimensional Images. Circ Cardiovasc Imaging 2018; 11:e006986.</a></li><li><a class="nounderline abstract_t">Michałowska I, Stokłosa P, Miłkowska M, et al. The role of cardiac computed tomography in the diagnosis of prosthetic valve endocarditis - A comparison with transthoracic and transesophageal echocardiography and intra-operative findings. Eur J Radiol 2021; 138:109637.</a></li><li><a class="nounderline abstract_t">Sifaoui I, Oliver L, Tacher V, et al. Diagnostic Performance of Transesophageal Echocardiography and Cardiac Computed Tomography in Infective Endocarditis. J Am Soc Echocardiogr 2020; 33:1442.</a></li><li><a class="nounderline abstract_t">Horgan SJ, Mediratta A, Gillam LD. Cardiovascular Imaging in Infective Endocarditis: A Multimodality Approach. Circ Cardiovasc Imaging 2020; 13:e008956.</a></li><li><a class="nounderline abstract_t">Feuchtner GM, Stolzmann P, Dichtl W, et al. Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings. J Am Coll Cardiol 2009; 53:436.</a></li><li><a class="nounderline abstract_t">Fagman E, Perrotta S, Bech-Hanssen O, et al. ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis. Eur Radiol 2012; 22:2407.</a></li><li><a class="nounderline abstract_t">Gahide G, Bommart S, Demaria R, et al. Preoperative evaluation in aortic endocarditis: findings on cardiac CT. AJR Am J Roentgenol 2010; 194:574.</a></li><li><a class="nounderline abstract_t">Salaun E, Habib G. Beyond Standard Echocardiography in Infective Endocarditis: Computed Tomography, 3-Dimensional Imaging, and Multi-Imaging. Circ Cardiovasc Imaging 2018; 11:e007626.</a></li><li><a class="nounderline abstract_t">Bruun NE, Habib G, Thuny F, Sogaard P. Cardiac imaging in infectious endocarditis. Eur Heart J 2014; 35:624.</a></li><li><a class="nounderline abstract_t">Orvin K, Goldberg E, Bernstine H, et al. The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis. Clin Microbiol Infect 2015; 21:69.</a></li><li><a class="nounderline abstract_t">Van Riet J, Hill EE, Gheysens O, et al. (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging 2010; 37:1189.</a></li><li><a class="nounderline abstract_t">de Camargo RA, Sommer Bitencourt M, Meneghetti JC, et al. The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Left-sided Endocarditis: Native vs Prosthetic Valves Endocarditis. Clin Infect Dis 2020; 70:583.</a></li><li><a class="nounderline abstract_t">Mahmood M, Kendi AT, Ajmal S, et al. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. J Nucl Cardiol 2019; 26:922.</a></li><li><a class="nounderline abstract_t">Duval X, Le Moing V, Tubiana S, et al. Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective Multicenter TEPvENDO Study. Clin Infect Dis 2021; 73:393.</a></li><li><a class="nounderline abstract_t">Duval X, Iung B, Klein I, et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med 2010; 152:497.</a></li><li><a class="nounderline abstract_t">Colen TW, Gunn M, Cook E, Dubinsky T. Radiologic manifestations of extra-cardiac complications of infective endocarditis. Eur Radiol 2008; 18:2433.</a></li><li><a class="nounderline abstract_t">Lecomte R, Issa N, Gaborit B, et al. Risk-benefit Assessment of Systematic Thoracoabdominal-pelvic Computed Tomography in Infective Endocarditis. Clin Infect Dis 2019; 69:1605.</a></li><li><a class="nounderline abstract_t">Meshaal MS, Kassem HH, Samir A, et al. Impact of routine cerebral CT angiography on treatment decisions in infective endocarditis. PLoS One 2015; 10:e0118616.</a></li><li><a class="nounderline abstract_t">Chakraborty T, Scharf E, DeSimone D, et al. Variable Significance of Brain MRI Findings in Infective Endocarditis and Its Effect on Surgical Decisions. Mayo Clin Proc 2019; 94:1024.</a></li><li><a class="nounderline abstract_t">Ahn Y, Joo L, Suh CH, et al. Impact of Brain MRI on the Diagnosis of Infective Endocarditis and Treatment Decisions: Systematic Review and Meta-Analysis. AJR Am J Roentgenol 2022; 218:958.</a></li><li><a class="nounderline abstract_t">Papadimitriou-Olivgeris M, Caruana G, Senn L, Guery B. Predictors of mortality of Staphylococcus aureus bacteremia among patients hospitalized in a Swiss University Hospital and the role of early source control; a retrospective cohort study. Eur J Clin Microbiol Infect Dis 2023; 42:347.</a></li><li><a class="nounderline abstract_t">Muñoz P, Bouza E, Marín M, et al. Heart valves should not be routinely cultured. J Clin Microbiol 2008; 46:2897.</a></li><li><a class="nounderline abstract_t">Fowler VG, Durack DT, Selton-Suty C, et al. The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clin Infect Dis 2023; 77:518.</a></li><li><a class="nounderline abstract_t">Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30:633.</a></li><li><a class="nounderline abstract_t">Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96:200.</a></li><li><a class="nounderline abstract_t">Dahl A, Fowler VG, Miro JM, Bruun NE. Sign of the Times: Updating Infective Endocarditis Diagnostic Criteria to Recognize Enterococcus faecalis as a Typical Endocarditis Bacterium. Clin Infect Dis 2022; 75:1097.</a></li><li class="breakAll">van der Vaart TW, Bossuyt PMM, Baddour LM, et al. External Validation of the 2023 Duke - International Society for Cardiovascular Infectious Diseases (ISCVID) Diagnostic Criteria for Infective Endocarditis (IE). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678423/ (Accessed on January 19, 2024).</li><li class="breakAll">Goehringer F, Lalloue B, Selton-Suty C, et al. Compared Performance Indices of the 2023 Duke-ISCVID, the 2000 Modified Duke, and the 2015 ESC Criteria for the Diagnosis of Infective Endocarditis. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678558/ (Accessed on January 19, 2024).</li><li><a class="nounderline abstract_t">Tattevin P, Watt G, Revest M, et al. Update on blood culture-negative endocarditis. Med Mal Infect 2015; 45:1.</a></li></ol></div><div id="topicVersionRevision">Topic 2143 Version 56.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26373316" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37622656" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : 2023 ESC Guidelines for the management of endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26341945" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14063073" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : CLINICAL SIGNIFICANCE OF SPLINTER HAEMORRHAGES.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25762500" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Classical eye signs in bacterial endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11479467" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Cardiac conduction abnormalities in endocarditis defined by the Duke criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9770144" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17881544" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Detection of bloodstream infections in adults: how many blood cultures are needed?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15227618" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Optimal testing parameters for blood cultures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4860941" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Studies on the bacteremia of bacterial endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19871447" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : OBSERVATIONS ON THE SITES OF REMOVAL OF BACTERIA FROM THE BLOOD IN PATIENTS WITH BACTERIAL ENDOCARDITIS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14972375" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : "Streptococcus milleri" endocarditis caused by Streptococcus anginosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/785000" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Streptococci and aerococci associated with systemic infection in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15057570" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8641002" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Diagnostic value of echocardiography in suspected endocarditis. An evaluation based on the pretest probability of disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22086858" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33342586" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20223755" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Recommendations for the practice of echocardiography in infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28483353" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Diagnostic Accuracy of Transthoracic Echocardiography for Infective Endocarditis Findings Using Transesophageal Echocardiography as the Reference Standard: A Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8712097" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A negative transthoracic echocardiogram obviates the need for transesophageal echocardiography in patients with suspected native valve active infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21685200" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23417650" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Staphylococcus aureus bacteraemia: evaluation of the role of transoesophageal echocardiography in identifying clinically unsuspected endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10816155" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Diagnostic accuracy of transthoracic and multiplane transesophageal echocardiography for valvular perforation in acute infective endocarditis: correlation with anatomic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1997851" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15310690" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Repeated echocardiographic examinations of patients with suspected infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29555833" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Comparison of Cardiac Computed Tomography With Transesophageal Echocardiography for Identifying Vegetation and Intracardiac Complications in Patients With Infective Endocarditis in the Era of 3-Dimensional Images.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33740628" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The role of cardiac computed tomography in the diagnosis of prosthetic valve endocarditis - A comparison with transthoracic and transesophageal echocardiography and intra-operative findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32981789" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Diagnostic Performance of Transesophageal Echocardiography and Cardiac Computed Tomography in Infective Endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32683888" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Cardiovascular Imaging in Infective Endocarditis: A Multimodality Approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19179202" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22622348" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20173130" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Preoperative evaluation in aortic endocarditis: findings on cardiac CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29555840" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Beyond Standard Echocardiography in Infective Endocarditis: Computed Tomography, 3-Dimensional Imaging, and Multi-Imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23900698" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Cardiac imaging in infectious endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25636930" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20204357" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30949690" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Left-sided Endocarditis: Native vs Prosthetic Valves Endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29086386" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32488236" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective Multicenter TEPvENDO Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20404380" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18523779" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Radiologic manifestations of extra-cardiac complications of infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30615098" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Risk-benefit Assessment of Systematic Thoracoabdominal-pelvic Computed Tomography in Infective Endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25823006" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Impact of routine cerebral CT angiography on treatment decisions in infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30922693" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Variable Significance of Brain MRI Findings in Infective Endocarditis and Its Effect on Surgical Decisions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35043667" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Impact of Brain MRI on the Diagnosis of Infective Endocarditis and Treatment Decisions: Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36729318" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Predictors of mortality of Staphylococcus aureus bacteremia among patients hospitalized in a Swiss University Hospital and the role of early source control; a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18632908" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Heart valves should not be routinely cultured.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37138445" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10770721" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8154507" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35262664" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Sign of the Times: Updating Infective Endocarditis Diagnostic Criteria to Recognize Enterococcus faecalis as a Typical Endocarditis Bacterium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35262664" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Sign of the Times: Updating Infective Endocarditis Diagnostic Criteria to Recognize Enterococcus faecalis as a Typical Endocarditis Bacterium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35262664" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Sign of the Times: Updating Infective Endocarditis Diagnostic Criteria to Recognize Enterococcus faecalis as a Typical Endocarditis Bacterium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25480453" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Update on blood culture-negative endocarditis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
